DrFirst has been at the forefront of electronic prescribing of controlled substances (EPCS) since it sent the nation’s first electronic prescription of a controlled substance. With EPCS legalized nationally, a majority of states have since mandated the use of EPCS for all controlled substances.
In addition, to handle the opioid epidemic, prescription drug monitoring programs (PDMPs) are operated and mandated at the state level to ensure prescribers have the information they need to identify patients who are addicted, or at risk of becoming addicted, to these dangerous drugs.
DrFirst™ offers two e-prescribing products that streamline workflow, inform medication reconciliation, and support medication adherence: the web-based Rcopia® software and the mobile app, iPrescribe®.
Are you ready for new regulations?
Nick Barger, PharmD, Vice President, Product at DrFirst teams up with Healthcare IT Today to create the Healthcare Regulatory Talk Series to explore emerging trends in regulatory. Are you ready to navigate the regulatory landscape with confidence?
Federal EPCS Requirement
As of January 1, 2023, The Centers for Medicare & Medicaid Services (CMS) requires all controlled substance prescriptions under Medicare’s Part D drug plan to be transmitted electronically. Additionally, the new compliance date for electronic prescriptions in Long Term Care facilities is January 1, 2025.
Click your state below to discover EPCS & PDMP compliance state requirements.